William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 125,792 shares at $64.74 ($8.1M) on 2020-05-07, disclosed to the SEC on 2020-05-11.
Open-market sale of $8.1M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.74 | 30,993 | $2.0M | 24.9% |
| 2 | $64.74 | 30,993 | $2.0M | 24.9% |
| 3 | $63.50 | 31,903 | $2.0M | 25.1% |
| 4 | $63.50 | 31,903 | $2.0M | 25.1% |
| Total | $64.11 avg | 125,792 | $8.1M | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |